NCT00512005View on ClinicalTrials.gov

VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2013

Conditions
Mitral Valve RegurgitationLeft Ventricular DysfunctionHeart FailureMitral InsufficiencyMitral IncompetenceIschemic Heart Disease
Interventions
DEVICE

Percutaneous mitral valve repair

Ventricular reshaping to treat functional mitral insufficiency

Trial Locations (4)

30322

RECRUITING

Emory University Hospital, Atlanta

55440

RECRUITING

Abbott Northwestern Hospital, Minneapolis

60201

RECRUITING

Evanston Northwestern Healthcare - Evanston Hospital, Evanston

66204

RECRUITING

Shawnee Mission Hospital, Shawnee Mission

Sponsors

Lead Sponsor

Myocor
All Listed Sponsors
lead

Myocor

INDUSTRY

NCT00512005 - VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study | Biotech Hunter | Biotech Hunter